Inventor
WAKEFIELD DARREN H
US49 patents
⚠️ This page may combine multiple inventors who share the name “WAKEFIELD DARREN H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARROWHEAD PHARMACEUTICALS INC
18 patentsUS10130651B2Nov 20, 2018
RNAi Therapy for Hepatitis B Virus Infection
ARROWHEAD PHARMACEUTICALS INC22 citations94
US10246709B2Apr 2, 2019
Targeting ligands for therapeutic compounds
ARROWHEAD PHARMACEUTICALS INC10 citations83
US10780108B2Sep 22, 2020
RNAi agents for Hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC5 citations82
US10662427B2May 26, 2020
Compositions and methods for inhibiting gene expression of LPA
ARROWHEAD PHARMACEUTICALS INC6 citations82
US9932586B2Apr 3, 2018
Compositions and methods for inhibiting gene expression of LPA
ARROWHEAD PHARMACEUTICALS INC9 citations82
US12188017B2Jan 7, 2025
Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin
ARROWHEAD PHARMACEUTICALS INC1 citations73
US10806750B2Oct 20, 2020
RNAi therapy for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC3 citations73
US10308941B2Jun 4, 2019
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC4 citations73
US11590156B2Feb 28, 2023
RNAi agents for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC2 citations72
US11517584B2Dec 6, 2022
RNAi agents for Hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC2 citations72
US11384355B2Jul 12, 2022
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
ARROWHEAD PHARMACEUTICALS INC3 citations72
US10927373B2Feb 23, 2021
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC2 citations71
US10316316B2Jun 11, 2019
Compositions for targeted delivery of siRNA
ARROWHEAD PHARMACEUTICALS INC1 citations69
US12116573B2Oct 15, 2024
Targeting ligands for therapeutic compounds
ARROWHEAD PHARMACEUTICALS INC0 citations62
US11534453B2Dec 27, 2022
RNAi therapy for hepatitis B virus infection
ARROWHEAD PHARMACEUTICALS INC0 citations62
US11840688B2Dec 12, 2023
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD PHARMACEUTICALS INC0 citations61
US10858658B2Dec 8, 2020
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD PHARMACEUTICALS INC0 citations52
US10047361B2Aug 14, 2018
Disulfide-containing alkyne linking agents
ARROWHEAD PHARMACEUTICALS INC0 citations51
ARROWHEAD MADISON INC
10 patentsUS9796756B2Oct 24, 2017
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
ARROWHEAD MADISON INC24 citations93
US9345775B2May 24, 2016
Compositions for targeted delivery of siRNA
ARROWHEAD MADISON INC5 citations84
US9803205B2Oct 31, 2017
Compositions and methods for inhibiting gene expression of factor XII
ARROWHEAD MADISON INC9 citations83
US10006025B2Jun 26, 2018
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
ARROWHEAD MADISON INC5 citations82
US9976141B2May 22, 2018
Compositions and methods for inhibiting gene expression of Hif2alpha
ARROWHEAD MADISON INC5 citations82
US9526796B2Dec 27, 2016
Peptide-based in vivo siRNA delivery system
ARROWHEAD MADISON INC3 citations73
US9089611B2Jul 28, 2015
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
ARROWHEAD MADISON INC2 citations56
US9803201B2Oct 31, 2017
Disulfide-containing alkyne linking agents
ARROWHEAD MADISON INC1 citations51
US9452221B2Sep 27, 2016
Poly(acrylate) polymers for in vivo nucleic acid delivery
ARROWHEAD MADISON INC0 citations47
US9474804B2Oct 25, 2016
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
ARROWHEAD MADISON INC0 citations45
ROZEMA DAVID B
8 patentsUS8313772B2Nov 20, 2012
Compositions for targeted delivery of siRNA
ROZEMA DAVID B159 citations99
US8501930B2Aug 6, 2013
Peptide-based in vivo siRNA delivery system
ROZEMA DAVID B180 citations98
US8137695B2Mar 20, 2012
Polyconjugates for in vivo delivery of polynucleotides
ROZEMA DAVID B138 citations98
US8658211B2Feb 25, 2014
Polyconjugates for in vivo delivery of polynucleotides
ROZEMA DAVID B71 citations97
US8426554B2Apr 23, 2013
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B47 citations97
US8802773B2Aug 12, 2014
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
ROZEMA DAVID B12 citations92
US9011919B2Apr 21, 2015
Compositions for targeted delivery of siRNA
ROZEMA DAVID B7 citations82
US8211468B2Jul 3, 2012
Endosomolytic polymers
ROZEMA DAVID B5 citations62
ROCHE MADISON INC
5 patentsUS8017109B2Sep 13, 2011
Endosomolytic poly(acrylate) polymers
ROCHE MADISON INC3 citations62
US8008355B2Aug 30, 2011
Endosomolytic poly(vinyl ether) polymers
ROCHE MADISON INC5 citations62
US7985406B2Jul 26, 2011
Membrane active heteropolymers
ROCHE MADISON INC2 citations62
US7470539B2Dec 30, 2008
Formation of polyampholytes in the presence of a polyion
ROCHE MADISON INC1 citations52
US7501394B2Mar 10, 2009
Compounds for targeting hepatocytes
ROCHE MADISON INC0 citations49
EMPIRICO INC
3 patentsWAKEFIELD DARREN H
3 patentsUS8932572B2Jan 13, 2015
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
WAKEFIELD DARREN H4 citations66
US8138383B2Mar 20, 2012
Membrane active heteropolymers
WAKEFIELD DARREN H3 citations61
US8933047B2Jan 13, 2015
Poly(acrylate) polymers for in vivo nucleic acid delivery
WAKEFIELD DARREN H3 citations56